4//SEC Filing
Vazquez Chris 4
Accession 0000905148-25-001609
CIK 0001439725other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 6:36 PM ET
Size
11.0 KB
Accession
0000905148-25-001609
Insider Transaction Report
Form 4
BIODESIX INCBDSX
Vazquez Chris
Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-05-12$0.36/sh−112$40→ 18,113 total - Sale
Common Stock
2025-05-13$0.35/sh−112$40→ 18,001 total - Exercise/Conversion
Restricted Stock Units
2025-05-09−602→ 1,805 total→ Common Stock (602 underlying) - Exercise/Conversion
Common Stock
2025-05-09+602→ 18,225 total
Footnotes (5)
- [F1]Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
- [F3]The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $0.3431 to $0.4014, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $0.3395 to $0.3622, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
Documents
Issuer
BIODESIX INC
CIK 0001439725
Entity typeother
Related Parties
1- filerCIK 0001980594
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 6:36 PM ET
- Size
- 11.0 KB